GSK cancer drug wins EU orphan status for small-cell lung cancer

5 days ago 5

GSK PLC (LSE:GSK, NYSE:GSK) has secured Orphan Drug Designation in the European Union for GSK5764227, also known as GSK’227, a B7-H3-targeted antibody-drug...

1. Homepage
2. Lung Cancer
3. GSK cancer drug wins EU orphan status for small-cell lung cancer